What's New New Analyst Reports Information What's New 07/26/2024NEWFerrotec Holdings(6890)Notice of the Capital Investment (Construction of a New Factory) by a Sensor Business Subsidiary in Lishui, ChinaNotice of the Establishment of a New Silicon Parts Company in Malaysia, the Increase in Capital in an Existing Subsidiary, the Conversion of an Existing Subsidiary to a Specified Subsidiary and Capital Investment (Construction of a New Factory)Notice of the Establishment of a New Metal Processing Company (Specified Subsidiary) in Changshan, China, the Increase in Capital in an Existing Subsidiary, the Conversion of an Existing Subsidiary to a Specified Subsidiary and Capital Investment (Construction of a New Factory)SEGA SAMMY HOLDINGS(6460)Notice regarding the Acquisition of Stakelogic B.V.Open Up Group(2154)Notice of Monthly Disclosure of Utilization Rates and Number of Domestic Engineers as of the end of June 2024EPCO(2311)Analyst Report(Shared Research) : Revision to the 1H FY12/24 earnings forecastSANYEI CORPORATION(8119)Analyst Report (FISCO Ltd.) 07/25/2024NEWEPCO(2311)Analyst Report(Shared Research) : Monthly results for June 2024IMAGICA GROUP(6879)Notice Regarding Completion of Disposal of Treasury Stock as Restricted Stock Compensation for Directors, etc.07/23/2024AEON DELIGHT(9787)Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY02/25 [Report Update] VT HOLDINGS(7593)Storm Research(Initiating coverage)07/22/2024TSUBURAYA FIELDS HOLDINGS(2767)Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for full-year FY03/24 [Report Update]ALINCO(5933)Analyst Report(Shared Research): Released Q1 FY03/25 results07/19/2024ALINCO(5933)Consolidated Financial Results for the Three Months Ended June 20, 2024 (Under Japanese GAAP)NS TOOL(6157)Notice regarding the completion of payment for the disposal of treasury stock as restricted stock compensationFerrotec Holdings(6890)Analyst Report(Shared Research): Announcements regarding the establishment of new companies, capital increases, and related mattersELECOM(6750)Notice Regarding the Terms and Conditions for the Issue of Stock Acquisition Rights as Stock OptionsNotice Regarding the Disposal of Treasury Stock as Restricted Stock CompensationASANTE(6073)Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation07/18/2024CRESCO(4674)Notice Concerning Disposal of Treasury Shares as Restricted Shares Remuneration for Directors and Employees of the Company, etcVT HOLDINGS(7593)Notice of 2024 Annual General Meeting and Meeting Materials07/17/2024Teijin(3401)Notice Concerning Completion of Payment for the Disposal of Treasury Shares as "Restricted Stock"TMS(4891)TMS Co., Ltd. to participate in BIO Asia-Taiwan 2024 Investment SummitSaint Marc Holdings(3395)Monthly Sales Report June 202407/16/2024Royal Holdings(8179)June 2024 Monthly Sales Report (Same-store sales)TOHO(9602)Consolidated Financial Results for the Three Months Ended May 31, 2024 (Under Japanese GAAP)07/12/2024HOTLAND(3196)Monthly Sales Report (June)ALPHA(4760)Consolidated Financial Results for the Nine Months Ended May 31, 2024 (Under Japanese GAAP)create restaurants holdings(3387)Financial Results of Fiscal 2025 Q1¡ÊSupplementary Material¡ËSummary of Business Results for the First Quarter Ending May 31, 2024 [IFRS] (Consolidated)TMS(4891)Non-consolidated Financial Results for the Three Months Ended May 31, 2024 [Japanese GAAP]&Do Holdings(3457)Announcement Regarding Change of Trade Name of Consolidated SubsidiaryFirst-corporation(1430)Summary of Financial Results for the fiscal year ended May 31, 2024 <Japan GAAP> (consolidated)07/11/2024Azplanning(3490)Consolidated Financial Results for the Three Months Ended May 31, 2024 (Under Japanese GAAP)CENTRAL SECURITY PATROLS(9740)Consolidated Financial Results for the Three Months Ended May 31, 2024 (Under Japanese GAAP) LAND(8918)Consolidated Financial Results for the Three Months Ended May 31, 2024 (Under Japanese GAAP)HUB(3030)Non-consolidated Financial Results for the Three Months Ended May 31, 2024 (Under Japanese GAAP)TSUBURAYA FIELDS HOLDINGS(2767)Notice of Completion of Payment of Disposal of Treasury Shares as Restricted Stock Compensation07/10/2024WATTS(2735)Consolidated Financial Results for the Nine Months Ended May 31, 2024 (Under Japanese GAAP)Home Position(2999)Non-consolidated Financial Results for the Nine Months Ended May 31, 2024 (Under Japanese GAAP) Tokyo Individualized Educational Institute(4745)Consolidated Financial Results for the Three Months Ended May 31, 2024 (Under Japanese GAAP)SOLXYZ(4284)FY12/24 Q1 Presentation Materials for Institutional InvestorsTOHO(9602)June 2024 Preliminary Report on Monthly Box Office Revenue (Distributed Dept./Movie Theater Chain)AEON DELIGHT(9787)Analyst Report(Shared Research) : Released Q1 FY02/25 results07/09/2024CRESCO(4674)[Delayed] Notice Concerning Completion of Reorganization Between the Company and Consolidated SubsidiariesVT HOLDINGS(7593)Presentation of Financial Results for the Year Ended March 31,2024HUB(3030)June 2024 Monthly ReportAEON DELIGHT(9787)Summary of Financial Results for the first quarter Ended May 31, 2024 [Japan GAAP] (Consolidated)Supplementary Information on the Financial Results for the Three Months Ended May 31, 2024The Monogatari Corporation(3097)Notice Regarding June 2024 Preliminary Monthly YoY Change in Sales and Number of RestaurantsVerite(9904)June 2024 Flash Report vs. LYFerrotec Holdings(6890)Notice of the Withdrawal of a Listing Application by Our Equity-Method Affiliate (Semiconductor Wafers)SWCC(5805)Small meeting for the Fiscal Year Ending March 2024 (movie)Small meeting for the Fiscal Year Ending March 2024AEON DELIGHT(9787)[Delayed]Notice Concerning Status of Acquisition of Treasury Stock07/08/2024ALPHA(4760)Notice Concerning Revisions to Full-Year Business Forecasts and Dividend Forecasts (Dividend Increase)Carna Biosciences(4572)Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY12/24 [Report Update]ASANTE(6073)June Monthly Sales Report for FY Ending March 2025NICHIREKI(5011)[Delayed]Notice of Disposal of Treasury Stock as Restricted Stock CompensationALINCO(5933)Analyst Report(Shared Research): Interview following the Announcement of Financial Results for full-year FY03/24 [Report Update]WATTS(2735)Notice Regarding June 2024 Monthly YoY Change in Sales and Number of ShopsASANTE(6073)Analyst Report(KAsset): Protect the environment and build customer confidence by extending the life of wooden houses and improving the wellbeing of employees.07/05/2024Ferrotec Holdings(6890)Analyst Report(Shared Research): Withdrawal of listing application for equity-method affiliate (a manufacturer of semiconductor wafers)Dream Incubator(4310)Analyst Report(Shared Research): Business alliance agreement with Dentsu SokenIMAGICA GROUP(6879)[Delayed]Notice Regarding Change of Directors[Delayed]Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation for Directors, etc.VT HOLDINGS(7593)Notice Regarding Personnel Changes of Directors and Corporate Auditors in connection with Transition to Company with Audit and Supervisory CommitteeNotice Regarding Partial Amendments to Articles of Incorporation in connection with Transition to Company with Audit and Supervisory CommitteeSummary of Consolidated Financial Results for the Year Ended March 31, 2024 (Based on IFRS) IMAGICA GROUP(6879)Notice of Resolution of the 51st Ordinary General Meeting of Shareholders07/04/2024Ad-Sol Nissin(3837)Notice Concerning Acquisition of Treasury SharesMcdonald's Holdings(Japan)(2702)Monthly IR NewsCUBE(7112)[Delayed] [FY12/24] Preliminary Monthly Sales Report of Directly Managed Stores for June 202407/03/2024Saint Marc Holdings(3395)Financial Results for FY3/24TMS(4891)TMS Enters into Exclusive License Agreement with Hokkaido University to In-License Novel Therapeutic Candidate for Spinal Cord InjuryEarth Corporation(4985)Notice on the Progress of the Acquisition of Own SharesFerrotec Holdings(6890)Notice of the Adjustment of Conversion Prices of Euro-Yen Denominated Convertible Bonds with Stock Acquisition Rights Due in 202807/02/2024TOP CULTURE(7640)FY10/2024 Preliminary sales figures (June)MELCO HOLDINGS(6676)Analyst Report(Shared Research) : Results of share buyback through off-auction tradingFast Fitness Japan(7092)Action to Implement Management that is Conscious of Cost of Capital and the Stock Price07/01/2024MELCO HOLDINGS(6676)Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for full-year FY03/24 [Report Update]SEGA SAMMY HOLDINGS(6460)Notice Regarding the Status of Acquisition of Treasury StocksMELCO HOLDINGS(6676)Notice Concerning Status of Purchase of Treasury Shares06/28/2024Ferrotec Holdings(6890)Analyst Report(Shared Research): Interview following the Announcement of Financial Results for full-year FY03/24 [Report Update] OKADA AIYON(6294)Notice Concerning Status of Compliance with Continued Listing Criteria for the Prime MarketFinancial Results for FY3/24Open Up Group(2154)Notice of Monthly Disclosure of Utilization Rates and Number of Domestic Engineers as of the end of May 202406/27/2024Segue Group(3968)[Delayed] Medium-term Management Plan (2024-2026)&Do Holdings(3457)(Progress of matters for disclosure) Announcement Regarding Completion of Transfer of Inventory AssetsTeijin(3401)Corporate Governance ReportCTI Engineering(9621)Notice of Measures to Prevent Recurrence of Inappropriate Cost ManagementALINCO(5933)[Delayed]Financial Results for the Fiscal Year Ended March 20, 2024 and Medium-Term Business Plan New Analyst Reports 7/26 EPCO Co.,Ltd.(2311) Analyst Report(Shared Research) : Revision to the 1H FY12/24 earnings forecast 7/24 SANYEI CORPORATION(8119) Analyst Report (FISCO Ltd.) 7/23 AEON DELIGHT CO.,LTD.(9787) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY02/25 [Report Update] 7/22 TSUBURAYA FIELDS HOLDINGS INC.(2767) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for full-year FY03/24 [Report Update] 7/19 ALINCO INCORPORATED(5933) Analyst Report(Shared Research): Released Q1 FY03/25 results 7/18 Ferrotec Holdings Corporation(6890) Analyst Report(Shared Research): Announcements regarding the establishment of new companies, capital increases, and related matters 7/8 Carna Biosciences, Inc.(4572) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY12/24 [Report Update] 7/4 Dream Incubator Inc.(4310) Analyst Report(Shared Research): Business alliance agreement with Dentsu Soken 7/1 MELCO HOLDINGS INC.(6676) Analyst Report(Shared Research) : Results of share buyback through off-auction trading 6/26 VT HOLDINGS CO.,LTD.(7593) Storm Research(Initiating coverage) 6/25 ASANTE INCORPORATED(6073) Analyst Report(KAsset): Protect the environment and build customer confidence by extending the life of wooden houses and improving the wellbeing of employees. 6/25 SBS Holdings,Inc(2384) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY12/24 [Report Update] 6/21 Royal Holdings Co., Ltd.(8179) Q&A sessions at the small meeting with analysts and institutional investors held on June 7,2024 Information Information 7/22 What's new: VT HOLDINGS (7593) Newly Added Company Date¡§7/22 VT HOLDINGS¡Ê7593¡§Prime¡Ë Latest Video & Presentations Latest Video&Slides Company newsprovided by Timely Disclosure Network News Release Stock Code or Name: 4552 JCR Pharmaceuticals Co.,Ltd. 07/23/2024 16:00 Notice Regarding the Disposition of Treasury Stock as Restricted Stock Compensation 07/18/2024 16:00 JCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th International Forum of Lysosomal Disorders 07/05/2024 15:30 JCR Organizes API Plant Tour for Local Residents 07/03/2024 16:00 [Delayed]Notice of Personnel and Organizational Changes 07/01/2024 16:00 MEDIPAL and JCR Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB 06/26/2024 16:00 Matters Concerning Controlling Shareholders (Affiliated Companies) 06/25/2024 18:30 JCR Pharmaceuticals Regains Full Commercialization Rights to JR-141 06/05/2024 08:00 Other Matters Subject to Measures for Electronic Provision When Convening the 49th Ordinary General Meeting of Shareholders 06/05/2024 08:00 Notice of Convocation of The 49th Ordinary General Meeting of Shareholders 05/31/2024 15:35 [Delayed]Financial Summary Consolidated Financial Results for the Year ended March 31, 2024 (FY2023) (Japanese standard) 05/24/2024 12:00 [Delayed]Appendix to the Consolidated Financial Summary FY2023 Second-Half (Full version) 05/13/2024 11:45 FY2023 Results Briefing Session -Material- 05/13/2024 11:30 [Updated] Appendix to the Consolidated Financial Summary FY2023 Second-Half (Flash report) 05/10/2024 17:00 Appendix to the Consolidated Financial Summary FY2023 Second-Half (Flash report) 05/10/2024 16:00 Notice Regarding Introduction of a Restricted Stock Compensation Plan and Revision to the Amount of Compensation for Directors 05/10/2024 16:00 Notice of Distribution of Retained Earnings 05/10/2024 16:00 Summary of Financial Results 2024 04/25/2024 16:00 Notice of Personnel Change 04/25/2024 16:00 Notice Regarding Nomination of a Candidate to the Board of Director 04/22/2024 14:00 JCR Pharmaceuticals Announces Naming Rights Partnership for "Uchibun" 03/19/2024 16:00 JCR Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion 02/28/2024 16:00 JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights its Commitment to the Rare Disease 02/28/2024 16:00 Notice of Director's Responsibility, Organizational and Personnel Changes 02/09/2024 10:30 [Delayed]Financial Summary Consolidated Financial Results for the Nine Months Ended December 31, 2023 (FY2023)(Japanese standard) 02/06/2024 17:00 [Delayed]FY2023 3rd Quarter Appendix to the Consolidated Financial Summary 01/24/2024 16:00 JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium 2024 12/20/2023 16:00 JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo 12/20/2023 16:00 JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration 12/20/2023 13:00 Notice of Change in Duties of Directors 12/14/2023 16:00 U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA) 11/28/2023 16:00 [Delayed]FY2023 First-Half Appendix to the Consolidated Financial Summary 11/21/2023 16:00 [Delayed] Financial Summary Consolidated Financial Results for the Six Months ended September 30, 2023 (FY2023) (Japanese standard) 11/07/2023 15:00 AlliedCel Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products 11/01/2023 17:00 FY2023 First-Half Results Briefing Session Presentation Material 10/27/2023 10:00 JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA 10/02/2023 11:00 PHC IVD and JCR Announce Upgrade of Melon Nikki Medication Management App for Pediatric Patients Undergoing Growth Hormone Therapy 09/29/2023 16:00 JCR Pharmaceuticals Announces 52-week Interim Data from its Global Phase I/II Study of JR-171 in Individuals with MPS I 09/28/2023 16:00 Revision of Consolidated Financial Forecasts for Fiscal Year Ended March 31, 2024 09/28/2023 16:00 MEDIPAL HOLDINGS and JCR Pharmaceuticals Conclude Two Agreements on Mucopolysaccharidosis Type IIIB Treatment 09/11/2023 16:00 [Delayed]Notice Regarding Recognition in the 2nd Hyogo Kobe Women's Empowerment Business (Mimoza Certified Company) Accreditation 09/01/2023 13:00 [Delayed]PHC IVD and JCR Announce GROWJECTOR Duo, a Motorized Digital Injector for Pediatric Patients Undergoing Gorwth Hormone Therapy 08/31/2023 16:00 Notice of Personnel Change 08/31/2023 16:00 Notice regarding Sponsorship for Relay for Life Japan 08/21/2023 13:55 [Delayed]Financial Summary Consolidated Financial Results for the Three Months ended June 30, 2023 (FY2023) (Japanese standard)